Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

Similar articles for PubMed (Select 23966120)

1.

Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome.

Davis JS, Pandya RK, Pizano LR, Namias N, Dearwater S, Schulman CI.

J Burn Care Res. 2013 Sep-Oct;34(5):492-7. doi: 10.1097/BCR.0b013e3182a2ad17.

PMID:
23966120
2.

Tracking non-burn center care: what you don't know may surprise you.

Davis JS, Dearwater S, Rosales O, Varas R, Quintana OD, Pizano L, Namias N, Schulman CI.

J Burn Care Res. 2012 Nov-Dec;33(6):e263-7. doi: 10.1097/BCR.0b013e3182504450.

PMID:
22878492
3.

27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.

Weinand C, Xu W, Perbix W, Lefering R, Maegele M, Rathert M, Spilker G.

Burns. 2013 Nov;39(7):1449-55. doi: 10.1016/j.burns.2013.03.011. Epub 2013 May 20.

PMID:
23702222
4.

DRG 272: does it provide adequate burn center reimbursement for the care of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis?

Kagan RJ, Edelman L, Solem L, Saffle JR, Gamelli R.

J Burn Care Res. 2007 Sep-Oct;28(5):669-74.

PMID:
17969245
5.

Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.

Barvaliya M, Sanmukhani J, Patel T, Paliwal N, Shah H, Tripathi C.

J Postgrad Med. 2011 Apr-Jun;57(2):115-9. doi: 10.4103/0022-3859.81865.

6.

Early treatment with nonsucrose intravenous immunoglobulin in a burn unit reduces toxic epidermal necrolysis mortality.

Aires DJ, Fraga G, Korentager R, Richie CP, Aggarwal S, Wick J, Liu DY.

J Drugs Dermatol. 2013 Jun 1;12(6):679-84.

PMID:
23839186
7.

Energy requirements of pediatric patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Mayes T, Gottschlich M, Khoury J, Warner P, Kagan R.

Nutr Clin Pract. 2008 Oct-Nov;23(5):547-50. doi: 10.1177/0884533608323434.

PMID:
18849560
8.

Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.

Morales ME, Purdue GF, Verity SM, Arnoldo BD, Blomquist PH.

Am J Ophthalmol. 2010 Oct;150(4):505-510.e1. doi: 10.1016/j.ajo.2010.04.026. Epub 2010 Jul 8.

PMID:
20619392
9.

Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients.

Kim HI, Kim SW, Park GY, Kwon EG, Kim HH, Jeong JY, Chang HH, Lee JM, Kim NS.

Korean J Intern Med. 2012 Jun;27(2):203-10. doi: 10.3904/kjim.2012.27.2.203. Epub 2012 May 31.

10.

Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Lipowicz S, Sekula P, Ingen-Housz-Oro S, Liss Y, Sassolas B, Dunant A, Roujeau JC, Mockenhaupt M.

Br J Dermatol. 2013 Apr;168(4):726-32. doi: 10.1111/bjd.12133. Epub 2013 Feb 16.

PMID:
23413807
11.

Adherence to burn center referral criteria: are patients appropriately being referred?

Carter JE, Neff LP, Holmes JH 4th.

J Burn Care Res. 2010 Jan-Feb;31(1):26-30. doi: 10.1097/BCR.0b013e3181cb8efb.

PMID:
20061833
12.

Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?

Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC.

Arch Dermatol. 2000 Mar;136(3):323-7.

PMID:
10724193
13.

Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Wong KC, Kennedy PJ, Lee S.

Australas J Dermatol. 1999 Aug;40(3):131-4.

PMID:
10439522
14.

Mortality and use of the auxiliary score in extensive toxic epidermal necrolysis patients admitted to an adult burns referral centre.

Mahar PD, Wasiak J, Cleland H, Watters D, Paul E, Marsh P, Gin D.

Dermatology. 2013;227(2):180-5. doi: 10.1159/000354264. Epub 2013 Sep 27.

PMID:
24080507
15.
16.

[Stevens-Johnson syndrome and toxic epidermal necrolysis: a 15-year retrospective study].

Moniz P, Casal D, Mavioso C, Castro JV, Almeida MA.

Acta Med Port. 2011 Jan-Feb;24(1):59-70. Epub 2011 Feb 28. Portuguese.

17.

Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States.

Moreau JF, Watson RS, Hartman ME, Linde-Zwirble WT, Ferris LK.

Pediatr Dermatol. 2014 Mar-Apr;31(2):163-8. doi: 10.1111/pde.12158. Epub 2013 May 16.

18.

Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.

Sane SP, Bhatt AD.

J Assoc Physicians India. 2000 Oct;48(10):999-1003. Review.

PMID:
11200928
19.

Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study.

Kannenberg SM, Jordaan HF, Koegelenberg CF, Von Groote-Bidlingmaier F, Visser WI.

QJM. 2012 Sep;105(9):839-46. doi: 10.1093/qjmed/hcs078. Epub 2012 Apr 28.

20.

Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008.

Zajicek R, Pintar D, Broz L, Suca H, K├Ânigova R.

J Eur Acad Dermatol Venereol. 2012 May;26(5):639-43. doi: 10.1111/j.1468-3083.2011.04143.x. Epub 2011 Jun 14.

PMID:
21668825
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk